Award
National Institute on Drug Abuse 11310871
Developing a computational platform for induced-fit and chemogenetic drug design
Recipient
Vanderbilt University
Awarded
March 20, 2026
Identifier
11310871
NIH grant awarded to Vanderbilt University for developing a computational platform for drug design targeting the μ-opioid receptor, focusing on biased/partial agonists and chemogenetic probes, with validation and a timeline through 2028.
Description
This is a NIH grant opportunity for developing a computational platform related to drug design targeting the μ-opioid receptor, with a focus on biased/partial agonists and chemogenetic probes. The project involves computational and experimental validation, with a multi-year timeline ending in 2028.